4.4 Review

Inhibition of IL-6 for the treatment of inflammatory diseases

Journal

CURRENT OPINION IN PHARMACOLOGY
Volume 4, Issue 4, Pages 386-391

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2004.03.005

Keywords

-

Ask authors/readers for more resources

Interleukin-6 (IL-6) is a pleiotropic cytokine with various biological activities. Deregulated overproduction of IL-6 has been found to play pathological roles in chronic inflammatory diseases such as rheumatoid arthritis, Castleman's disease, juvenile idiopathic arthritis and Crohn's disease. Humanized anti-IL-6 receptor antibody has been developed as a therapeutic agent for these diseases, and therapeutic benefits have been revealed in clinical studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available